Disease modelling is one of the most critical components of drug discovery, allowing researchers to understand underlying disease mechanisms and effectively identify and validate therapeutic targets.
Our disease modelling capabilities are based upon a combination of expertise, innovative tools and customised solutions including:
Co-Culture Systems
Cell Line Engineering
3D Culture Systems
Patient Models
We employ co-culture systems that incorporate multiple cell types to study complex cell-cell interactions and their roles in disease progression. These models are particularly useful for investigating the tumour microenvironment and immune cell dynamics.
We employ co-culture systems that incorporate multiple cell types to study complex cell-cell interactions and their roles in disease progression. These models are particularly useful for investigating the tumour microenvironment and immune cell dynamics.
Our expertise in cell line engineering allows us to generate custom cell lines, developed specifically to meet your research needs.
Our advanced 3D culture systems provide more physiologically relevant conditions compared to traditional 2D cultures. These models better replicate the architecture and microenvironment of tissues, offering more accurate data on drug efficacy and toxicity.
Organoid models, derived from patient tissues and created with our partner ScreenIn3D, provide a powerful platform for studying disease biology and drug responses in a context that closely resembles in vivo conditions.
Difficulty doesn’t deter us; it inspires us. Give us a problem, and we’ll find your solution. Learn more about our range of in vitro assays and bioanalytical assessments in our Capabilities brochure.
